61 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
AMPH Amphastar Pharmaceuticals, Inc. $18.33 $847.88M N/A
Article Searches
Amphastar Pharmaceuticals (AMPH) Q4 2017 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/03/14/amphastar-pharmaceuticals-amph-q4-2017-earnings-co.aspx?source=iedfolrf0000001 Mar 14, 2018 - AMPH earnings call for the period ending December 31, 2017.
Amphastar Pharmaceuticals Inc (AMPH) Files 10-K for the Fiscal Year Ended on December 31, 2017 http://www.gurufocus.com/news/652395/amphastar-pharmaceuticals-inc-amph-files-10k-for-the-fiscal-year-ended-on-december-31-2017 Mar 14, 2018 - Amphastar Pharmaceuticals Inc (AMPH) Files 10-K for the Fiscal Year Ended on December 31, 2017, Stocks: AMPH, release date:Mar 14, 2018
AMPH: Needham reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180313093908 Mar 13, 2018 - Needham issues rating change for AMPH
Amphastar Pharmaceuticals' (AMPH) CEO Yongfeng Zhang on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4155751-amphastar-pharmaceuticals-amph-ceo-yongfeng-zhang-q4-2017-results-earnings-call-transcript?source=feed_sector_healthcare Mar 12, 2018 - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2017 Earnings Conference Call March 12, 2018, 17:00 ET Executives Jason Shandell - President William Peters - CFO Yongfeng Zhang - CEO Analysts David A
M&A, Innovation & New Drugs to Drive Pharma Stocks http://www.zacks.com/commentary/152408/ma-innovation-new-drugs-to-drive-pharma-stocks?cid=CS-ZC--152408 Mar 08, 2018 - M&A, Innovation & New Drugs to Drive Pharma Stocks
Mallinckrodt PLC (MNK) Jumps: Stock Rises 15.3% http://www.zacks.com/stock/news/294063/mallinckrodt-plc-mnk-jumps-stock-rises-153?cid=CS-ZC--294063 Feb 28, 2018 - Mallinckrodt PLC (MNK) shares rose more than 15% in the last trading session, amid huge volumes.
Key Factors to Influence Penumbra's (PEN) Earnings in Q4 http://www.zacks.com/stock/news/293085/key-factors-to-influence-penumbras-pen-earnings-in-q4?cid=CS-ZC-FT-293085 Feb 21, 2018 - Penumbra (PEN) expects to gain from solid performance by neuro and peripheral vascular arms in Q4. Strong growth across all geographies is likely to drive the top line.
What's in Store for Veeva Systems (VEEV) in Q4 Earnings? http://www.zacks.com/stock/news/293083/whats-in-store-for-veeva-systems-veev-in-q4-earnings?cid=CS-ZC-FT-293083 Feb 21, 2018 - Consistent focus on Subscription Services is likely to drive Veeva Systems (VEEV) in Q4.
Is a Beat in Store for Inogen (INGN) This Earnings Season? http://www.zacks.com/stock/news/293072/is-a-beat-in-store-for-inogen-ingn-this-earnings-season?cid=CS-ZC-FT-293072 Feb 21, 2018 - Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.
Can PBM Unit Drive Express Scripts' (ESRX) Earnings in Q4? http://www.zacks.com/stock/news/293001/can-pbm-unit-drive-express-scripts-esrx-earnings-in-q4?cid=CS-ZC-FT-293001 Feb 20, 2018 - Express Scripts (ESRX) expects Q4 results to show earnings growth on strength in PBM segment.

Pages: 1234567

<<<Page 4>